Categories Earnings, Health Care

Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results

Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year guidance.

  • Third-quarter revenue increased modestly to $10.60 billion from $10.57 billion in the comparable period last year
  • Earnings, on a reported basis, declined to $4.25 in the September quarter from $4.42 in the year-ago quarter
  • On an adjusted basis, Q3 earnings dropped to $5.28 per share from $5.69 per share in the third quarter of 2023
  • Operating income for the third quarter was $1.84 billion, compared to $1.86 billion in the year-ago quarter
  • The company raised its full-year EPS guidance to the range of $21.35 to $22.07 from the previous guidance of $21.29 to $22.07
  • It continues to expect fiscal 2024 revenue to be between $42.4 billion and $43.3 billion

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%

Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted

Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top